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clotting factors implies a geographic location near a referral center. Prostheses
are mainly used for the hip, knee, and elbow; arthrodesis is often preferred for
the ankle joint.
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a répétition des hémarthroses provoque des lésions articulaires responsables
e retentissements fonctionnels variables d’un patient à l’autre. Comme pour
es pathologies dégénératives habituelles, il y a peu de parallélisme anatomo-
linique. En conséquence, l’indication chirurgicale ne dépend pas uniquement
e l’évolution radiographique, mais essentiellement de la plainte fonctionnelle.
’importance de la dégradation articulaire constatée sur les arthropathies hémo-
hiliques, (notamment, le coude, le genou ou la cheville) conduit le chirurgien
réalisé souvent des arthrodèses ou des arthroplasties prothétiques.
’acte chirurgical impose bien évidemment une prise en charge multidiscipli-
aire. L’importance des raideurs existantes et surtout leur chronicité, nécessite
’associer un travail de rééducation souvent en préopératoire et systématique
n postopératoire. Le coût du traitement substitutif en facteurs de coagulation
mpose une localisation géographique dans un centre référent.
es prothèses sont essentiellement utilisées sur la hanche, le genou et le coude ;
es arthrodèses sont souvent préférées sur l’articulation de la cheville.
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he coagulation process can be activated by two pathways: the cascade reactions
an be initiated by the contact phase (intrinsic pathway) and/or the presence of
issue factor (TF) can induce coagulation via the extrinsic pathway. The injured
issue induces release of TF, a phenomenon now confirmed as the main process
ctivating coagulation, leading to maximal thrombin generation and fibrin clot
ormation. However, the two anti-hemophilic factors (Factors VIII and IX) do
ot belong to this extrinsic coagulation pathway. Thus, it was initially difficult to
xplain why patients with hemophilia (in whom the main coagulation pathway
s preserved) do suffer from hemorrhagic symptoms.
n the 1970s, Franc¸ois Josso et al. demonstrated that the first steps of the coagu-
ation activation always require factor V and Factor VIII activation (now defined
s the “Josso loop”), that thrombin generation plays a major role in this process
nd suggested that another coagulation pathway could be critical to explain the
redisposition of joints to bleed in patients with hemophilia. Since this first
escription, it has been demonstrated that TF can be identified in many tissues
epidermal tissues, digestive mucosa, aero-digestive tract), but not in plasma,
ormal blood cells, in joint tissue and striated muscle. So, when there is no TF,
he extrinsic pathway becomes the major pathway and its dysfunction could
asily lead to abnormal bleedings. These locations are then predisposed to bleed
n hemophilic patients.
n the absence of prophylaxis, the hemophilic arthropathy often takes place very
arly in children with severe hemophilia, mainly located in knees, ankles and
lbows. Hemarthrosis is usually accompanied by rapid pain, joint swelling and
uscular dysfunction. With adapted substitution treatment (Factor VIII or IX
oncentrates), these clinical signs disappear in a few days. In contrast, the repeti-
ion of these joint bleedings induces a progressive destruction of the cartilage and
ertain synovia alterations. This joint destruction is the first cause of morbidity
hat can alter the quality of life of hemophilia patients.
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bjective.– Haemophilia is responsible for joint bleedings because of coagu-
ation factor deficit. When bleedings are repeated, a vicious circle ends in a
rogressive and complete destruction of joints. The purpose of this lecture is to
how how this destruction occurs clinically while focusing on various preventive
herapeutic options.
ethod.– After a brief reminder of the physiopathological factors of haemo-
hiliac joint diseases, various joint topographies are described. Clinical and
adiological evolution is shown from clinical cases. Various clinical scores are
lso discussed. The clinical course of the joint is discussed, according to pre-
entive treatment with anti-haemophilic factors and according to the presence
f an inhibitor. The various conservative treatments used at different stages of
oint destruction are exposed.
esults.– Three joints, elbows, knees and ankles have a particularly high risk of
estruction. According to the possibilities of disease prevention, 1 to 3 joints will
e destroyed by the age of 20 years versus 5 if no preventive treatment is given.
he presence of an inhibitor is a powerful protection for joint integrity. Physical
edicine and rehabilitation treatments are used to restore deficiencies and to
mprove pain relief. Synoviorthesis attempts to limit the synovial proliferation
hich evolves on the own and participates in the joint degradation.
iscussion.– Preservation of joints in haemophiliac subjects depends on disease
revention with anti-haemophilic factors but also on exposure to risk resul-
ing from proposed activities and compliance with an annual joint follow-up
o guarantee early treatment of haemarthrosis and early-stage arthropathy. This
pecific assessment requires multidisciplinary medical cooperation to protect
oint integrity throughout the life of the haemophiliac subject.
oi:10.1016/j.rehab.2011.07.678
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epeated hemarthrosis causes joint damage responsible for functional impair-
ent variable from one patient to another. As usual with degenerative diseases,
here are no predicting factors on radiographs. Consequently, the indication
or surgery depends not only on radiographic progression, but essentially the
unctional complaint.
he importance of joint damage seen in hemophilic arthropathy (especially
lbow, knee or ankle) often leads the surgeon to perform arthrodesis or prosthe-
ic replacements. The surgery obviously requires a multidisciplinary approach.
he significant stiffness and especially its chronicity, requires systematic post-
perative rehabilitation and sometimes preoperative rehabilitation. The cost of
